Search This Blog

Thursday, August 11, 2022

Virios corporate update

 

  • Completed patient dosing in Phase 2b FORTRESS fibromyalgia study

  • Top line FORTRESS results expected in September 2022

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.